Literature DB >> 22760810

Experimental models of autoimmune inflammatory ocular diseases.

Fabio Gasparin1, Beatriz Sayuri Takahashi, Mariana Ramos Scolari, Filipe Gasparin, Lycia Sampaio Pedral, Francisco Max Damico.   

Abstract

Ocular inflammation is one of the leading causes of blindness and loss of vision. Human uveitis is a complex and heterogeneous group of diseases characterized by inflammation of intraocular tissues. The eye may be the only organ involved, or uveitis may be part of a systemic disease. A significant number of cases are of unknown etiology and are labeled idiopathic. Animal models have been developed to the study of the physiopathogenesis of autoimmune uveitis due to the difficulty in obtaining human eye inflamed tissues for experiments. Most of those models are induced by injection of specific photoreceptors proteins (e.g., S-antigen, interphotoreceptor retinoid-binding protein, rhodopsin, recoverin, phosducin). Non-retinal antigens, including melanin-associated proteins and myelin basic protein, are also good inducers of uveitis in animals. Understanding the basic mechanisms and pathogenesis of autoimmune ocular diseases are essential for the development of new treatment approaches and therapeutic agents. The present review describes the main experimental models of autoimmune ocular inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22760810     DOI: 10.1590/s0004-27492012000200016

Source DB:  PubMed          Journal:  Arq Bras Oftalmol        ISSN: 0004-2749            Impact factor:   0.872


  10 in total

1.  Characterization of microRNA expression profiling in peripheral blood lymphocytes in rats with experimental autoimmune uveitis.

Authors:  Dadong Guo; Jiao Li; Zhengfeng Liu; Kai Tang; Huixin Song; Hongsheng Bi
Journal:  Inflamm Res       Date:  2015-07-08       Impact factor: 4.575

2.  CAPN5 mutation in hereditary uveitis: the R243L mutation increases calpain catalytic activity and triggers intraocular inflammation in a mouse model.

Authors:  Katherine J Wert; Alexander G Bassuk; Wen-Hsuan Wu; Lokesh Gakhar; Diana Coglan; MaryAnn Mahajan; Shu Wu; Jing Yang; Chyuan-Sheng Lin; Stephen H Tsang; Vinit B Mahajan
Journal:  Hum Mol Genet       Date:  2015-05-20       Impact factor: 6.150

Review 3.  Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation.

Authors:  Michelle L Ratay; Elena Bellotti; Riccardo Gottardi; Steven R Little
Journal:  Adv Healthc Mater       Date:  2017-10-16       Impact factor: 9.933

4.  Acid Ceramidase Deficiency in Mice Leads to Severe Ocular Pathology and Visual Impairment.

Authors:  Fabian P S Yu; Benjamin S Sajdak; Jakub Sikora; Alexander E Salmon; Murtaza S Nagree; Jiří Gurka; Iris S Kassem; Daniel M Lipinski; Joseph Carroll; Jeffrey A Medin
Journal:  Am J Pathol       Date:  2018-11-23       Impact factor: 4.307

Review 5.  Mechanisms of sterile inflammation after intravitreal injection of antiangiogenic drugs: a narrative review.

Authors:  William J Anderson; Natasha Ferreira Santos da Cruz; Luiz Henrique Lima; Geoffrey G Emerson; Eduardo Büchele Rodrigues; Gustavo Barreto Melo
Journal:  Int J Retina Vitreous       Date:  2021-05-07

6.  Dietary Omega-3 Fatty Acids Suppress Experimental Autoimmune Uveitis in Association with Inhibition of Th1 and Th17 Cell Function.

Authors:  Hiromi Shoda; Ryoji Yanai; Takeru Yoshimura; Tomohiko Nagai; Kazuhiro Kimura; Lucia Sobrin; Kip M Connor; Yukimi Sakoda; Koji Tamada; Tsunehiko Ikeda; Koh-Hei Sonoda
Journal:  PLoS One       Date:  2015-09-22       Impact factor: 3.240

7.  Proteasome inhibitor bortezomib suppresses nuclear factor-kappa B activation and ameliorates eye inflammation in experimental autoimmune uveitis.

Authors:  Sheng-Min Hsu; Chang-Hao Yang; Fang-Hsiu Shen; Shun-Hua Chen; Chia-Jhen Lin; Chi-Chang Shieh
Journal:  Mediators Inflamm       Date:  2015-01-12       Impact factor: 4.711

Review 8.  Immunopathogenic Background of Pars Planitis.

Authors:  Joanna Przeździecka-Dołyk; Agnieszka Węgrzyn; Anna Turno-Kręcicka; Marta Misiuk-Hojło
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2015-10-05       Impact factor: 4.291

Review 9.  Immunotherapeutic strategies in autoimmune uveitis.

Authors:  Pedro Henrique Papotto; Eliana Blini Marengo; Luiz Roberto Sardinha; Anna Carla Goldberg; Luiz Vicente Rizzo
Journal:  Autoimmun Rev       Date:  2014-05-12       Impact factor: 9.754

10.  Chitosan Oligosaccharides Suppress Nuclear Factor-Kappa B Activation and Ameliorate Experimental Autoimmune Uveoretinitis in Mice.

Authors:  Sheng-Min Hsu; Chang-Hao Yang; Hsien-Yang Tsai; Chia-Jhen Lin; Yi-Hsuan Fang; Chi-Chang Shieh; Shun-Hua Chen
Journal:  Int J Mol Sci       Date:  2020-11-06       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.